Mangalam Drugs & Organics informs about disclosures

02 Jul 2022 Evaluate

Mangalam Drugs & Organics has informed that the 'Company along with the other appellants' ('Appellants'), have challenged the order dated September 22 2020, passed by the Whole time member ('WTM') of Securities and Exchange Board of India SEBI (SEBI), before Securities Appellate Tribunal ('SAT'). In continuation of that, an order was pronounced by the SAT. In terms of the order passed by the SAT, the impugned order passed by the SEBI against the Company cannot be sustained and hence quashed. The Copy of the SAT order is herewith attached for your reference. The Company is in the process of receiving the Certified Copy of the Order from the Registry.

The above information is a part of company’s filings submitted to BSE.

Mangalam Drugs&Org. Share Price

106.90 2.10 (2.00%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.